A Look at the Future of Blood-Based Companion Diagnostics

Three leading experts in liquid biopsy diagnostic development, Gary Pestano, Viresh Patel and Dawne Shelton bring you insight into the developmental blueprint for blood-based IVDs. Novel case study data on the development of blood-based MSI, ALK, ROS and RET assays are discussed.

Pre-Analytical Variable Considerations in the Development of Robust DNA and RNA ddPCR Assays

Learn how Streck blood collection tubes can help preserve valuable samples for liquid biopsy assay development. Hestia Mellert, PhD, Director of Molecular Product Development at Biodesix, describes pre-analytical considerations with the GeneStrat® genomic test.

Presented April 4, 2017 at American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C.

Whose Patient is it Anyways? – The Oncologist Perspective

Paul Walker, MD, FACP
Chief of Hematology/Oncology
Brody School of Medicine
East Carolina University and Vidant Medical Center

Presented February 18, 2017 at the 11th Annual Global Lung Health Summit in Amelia Island, Florida

Victoria’s Story

Victoria Bannister discovered that she had lung cancer during an unrelated doctor visit in early 2016. While seeking treatment she became frustrated with the long turnaround time on traditional tissue biopsy results. With the blood-based Biodesix Lung Reflex testing strategy, Victoria received her genomic and proteomic results in 72 hours and was able to quickly initiate treatment with a targeted therapy.

Applied Machine Learning in the Development of Immuno-Oncology Diagnostics

Mario Sznol, MD
Professor of Medicine – Medical Oncology
Co-Director, Cancer Immunology Program at Yale Cancer Center
Co-Director, Yale SPORE in Skin CancerFacility
Yale Cancer Center

Heinrich Roder, D.Phil
Chief Technology Officer
Biodesix, Inc